Mario Giraldo‐Velásquez

Author

Also Known As

M.A. Giraldo-Velásquez, Mario Giraldo-Velasquez, Mario Giraldo-Velásquez, Mario Giraldo‐Velasquez, Mario Giraldo‐Velásquez

Publications

463

Citations

H-Index

Concepts

All Affiliations

University of Würzburg Justus-Liebig-Universität Gießen University of Göttingen Sozialstiftung Bamberg Freie Universität Berlin

About

Mario Giraldo‐Velásquez is an author at University of Würzburg specializing in medicine, neuroimmunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	325
2	Cell Biology	3	3	254
3	Health Sciences	1	1	136
4	Epidemiology	1	1	71
5	Immunology	1	1	87

Mario Giraldo‐Velásquez

Publications

459

Citations

H-Index

Page 1

	Year	Citations
Toxoplasma gondii in Primary Rat CNS Cells: Differential Contribution of Neurons, Astrocytes, and Microglial Cells for the Intracerebral Development and Stage Differentiation Carsten G. K. Lüder, Mario Giraldo‐Velásquez, Michael Sendtner Experimental Parasitology Neurobiology Of DiseaseStage DifferentiationHealth SciencesEpendymaNeuroanatomy	1999	136
Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA Carsten G. K. Lüder, Christine Lang, Mario Giraldo‐Velásquez, Journal of Neuroimmunology Autoimmune DiseaseMedicineImmunologyImmune RegulationImmunologic Mechanism	2003	87
The Neuropathology and Epidemiology of AIDS A. J. Martinez, Manfred Sell, T. Mitrovics, Pathology - Research and Practice Sexual HealthEpidemiologyTreatment And PreventionNeurovirologyMedicine	1995	71
No Association of the Structural Dopamine D2 Receptor (DRD2) Variant <sup>311</sup>Cys with Alcoholism Ulrich Finckh, Ole von Widdern, Mario Giraldo‐Velásquez, Alcoholism Clinical and Experimental Research	1996	35
Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through <scp>ERK/AKT</scp> phosphorylation R. Rajendran, Mario Giraldo‐Velásquez, Christine Stadelmann, Brain Pathology	2017	34
Fgfr2 and Fgfr3 are not required for patterning and maintenance of the midbrain and anterior hindbrain Alexandra Blak, Thorsten Naserke, Jonna Saarimäki‐Vire, Developmental Biology Developmental BiologyBone Morphogenic ProteinCraniofacial DevelopmentMorphogenesisAnterior Hindbrain	2006	31
Dopamine D2 receptor gene (DRD2) haplotypes in Caucasians Ulrich Finckh, Mario Giraldo‐Velásquez, Jörg Pelz, Gene Human PolymorphismGeneticsGenetic EpidemiologyDopamine	1996	25
Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG<sub>35‐55</sub>‐induced EAE through ERK and Akt signalling Salar Kamali, R. Rajendran, Christine Stadelmann, Brain Pathology	2020	25
Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE R. Rajendran, Vinothkumar Rajendran, Mario Giraldo‐Velásquez, International Journal of Molecular Sciences	2021	15

Page 1